With a 3,000 lb cultivation facility in Puerto Rico, a Colombian grow facility in development, manufacturing and extractions biz (2,000 lb capacity) in California and distribution to retail storefronts in California – CSI is on the move.
The 5,000 square feet Arizona manufacturing facility is a “turn key solution” that produces 100% cannabidiol (CBD)-based products, such as “hard and soft-capsules, cartridges, lotions, tinctures, and other liquid formulations.”
Chemesis has also signed an endorsement deal with a duo that Equity Guru’s Chris Parry calls, “One of the top three best endorsement targets (for a cannabis company) in the world today.” Hint: one of them doesn’t speak.
Edgar Montero, the CEO of Chemesis, spoke with Equity.Guru’s Guy Bennett about the personal catalyst that propelled him into the cannabis industry, and how CSI cross-pollinates innovation between its international operations.
Full disclosure: Chemesis International is an Equity.Guru marketing client.
Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
Latest posts by Lukas Kane (see all)
- Vext Science (VEXT.C) ramps up Hemp/CBD operation in Kentucky - February 13, 2020
- How Canada’s Shopify (SHOP.T) just kicked Amazon’s (AMZN.Q) ass - February 12, 2020
- Sprint (S.NYSE), T-Mobile (TMUS.Q) gain $41 billion after gullible judge gives thumbs up to mega-merger - February 11, 2020